Prometheus Laboratories is enrolling patients for Proclivity 01, a multi-center study of Proleukin (High Dose Interleukin-2 (HD IL-2)) combined with vemurafenib therapy in patients with Braf V600 mutation-positive metastatic melanoma (mM). ...
Tags: Prometheus, Proclivity 01 Study
Cubist Pharmaceuticals has received the US Food and Drug Administration (FDA) fast track status for its late-stage antibiotic candidate ceftolozane/tazobactam in the previously granted Qualified Infectious Disease Product (QIDP) ...
Tags: Cubist, Fast Track Status
Oncology-focused company Curis has announced the approval of Erivedge (vismodegib) in Australia for the treatment of metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma in adult patients who are not suitable for ...
Tags: Curis, Erivedge Anti-Cancer Drug
Who wouldn't like to loosen up in a cozy bathtub and beat all the weariness that pulls one down at the end of the day, or simply to rejuvenate oneself over the weekend, or just to have a fresh start to a tiring day? How about having a deep ...
Tags: Deep Bathtubs, Bathtubs
Soaking yourself in a bathtub is the best way to relax after a eventful day. These bathtubs are one of the most popular as they allow you to have the perfect soaking experience. While previous soaking bathtubs just provided soaking of lower ...
Tags: Soaking Bathtubs
St. Jude Medical, a US-based medical device company, has announced CE Mark approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy ...
Tags: St.Jude Medical, Mark
ME System, a product innovation company, today announces the start of its first-ever crowd funding campaign in anticipation of the release of its first product to market – the ME Clock. With an Indiegogo campaign that will run ...
Tags: ME System Raising Funds, Indiegogo
Merck, referred to as MSD outside the US and Canada, has obtained FDA approval for Liptruzet tablets as an adjunctive therapy to diet for the treatment of elevated low-density lipoprotein (LDL) cholesterol in primary or mixed hyperlipidemia ...
Tags: Merck, Liptruzet Tablets
If you've ever had trouble affording your medications and wanted to call your doctor on it, here's some encouraging news: Doctors aren't pleased about the prices either. Denouncing "profiteering" by pharmaceutical companies, more than 100 ...
ResMed has launched its home variable positive airway pressure (VPAP) device in the US for the treatment of respiratory disorders such as chronic obstructive pulmonary disease (COPD). Used at night, VPAP COPD device helps the patients to ...
Tags: COPD Treatment Device, ResMed
Germany-based Activaero has extended its collaboration agreement with TransMIT, Gesellschaft für Technologietransfer, the technology transfer agency of Justus-Liebig-University Giessen, to develop the treatment of pulmonary ...
Tags: Pulmonary Hypertension, Health
There are some trips that just wouldn't be right without your best furry friend. Taking a pet along for the ride can be a complicated pursuit—but if you're prepared, you can simplify the process significantly. Whether you're moving, ...
Tags: dog travel, pet travel
Here's some mattress marketing gold from a survey that Furniture Today conducted with its research partner, Apartment Therapy. Newer mattresses have higher sleep satisfaction scores than older mattresses. In fact, the newest mattresses ...
Tags: Mattress, Better Sleep
Teva Pharmaceutical and Xenon Pharmaceuticals have announced the FDA orphan drug designation for analgesic XEN402 being developed to treat pain associated with erythromelalgia (EM). The novel chemical entity XEN402 is designed to inhibit ...
Tags: Pharmaceutical, FDA, Orphan Drug
US-based medical devices manufacturer Varian Medical and Paul Scherrer Institute (PSI) have collaborated to further advance the motion management techniques for proton therapy. Focused on optimizing treatment strategies for cancer in the ...
Tags: Varian Medical, Proton Therapy